USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
June 09, 2023 15:48 ET
|
PharmAla Biotech
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE:...
全球知名監管專家、前BMS集團副總裁 王慧君博士 出任台灣浩鼎CEO
June 02, 2023 03:11 ET
|
OBI Pharma USA
她在製藥業成績顯赫；曾率BMS團隊在五大治療領域，開發九種首創新藥在美國成功上市，並推廣至世界各地，嘉惠病患無數。 台灣台北, June 02, 2023 (GLOBE NEWSWIRE) --...
全球知名监管专家、前BMS集团副总裁 王慧君博士 出任台湾浩鼎CEO
June 02, 2023 03:11 ET
|
OBI Pharma USA
她在制药业成绩显赫; 曾率BMS团队在五大治疗领域，开发九种首创新药在美国成功上市，并推广至世界各地，嘉惠病患无数。 台湾台北, June 02, 2023 (GLOBE NEWSWIRE) --...
OBI Pharma Announces Executive Leadership Management Change – Heidi Wang, Ph.D. Appointed as Chief Executive Officer
June 02, 2023 03:11 ET
|
OBI Pharma Inc.
Dr. Wang appointed by the OBI Pharma Board of Directors as Chief Executive Officer to lead OBI Pharma with a vision and to bring innovative cancer therapies to patients globally. She brings a wealth...
SPOK TO PRESENT AT THE INAUGURAL EF HUTTON GLOBAL CONFERENCE
May 08, 2023 09:35 ET
|
Spok Holdings, Inc.
ALEXANDRIA, Va., May 08, 2023 (GLOBE NEWSWIRE) -- via IBN -- Spok Holdings, Inc. (NASDAQ: SPOK) today announced that Vincent D. Kelly, president and chief executive officer, will be presenting at...
Clinical Trial Imaging Market is Growing Rapidly Due to the Increasing Use of Imaging in Clinical Trials to Assess the Efficacy and Safety of Drugs and Medical Devices
April 27, 2023 10:32 ET
|
Beyond Market Insights
Ottawa, April 27, 2023 (GLOBE NEWSWIRE) -- Beyond Market Insights, a leading market research firm has recently published a comprehensive report on the "Clinical Trial Imaging Market Size, Share,...
OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease
April 25, 2023 02:00 ET
|
OKYO Pharma LTD
LONDON and NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
Global In-vitro Fertilization Microscopes Market Expected to Generate a Revenue of $250.4 Million and Grow at a Healthy CAGR of 9.4% in the 2022-2031 Timeframe [240-Pages] | Depicted by Research Dive
April 24, 2023 10:30 ET
|
Research Dive
New York, USA, April 24, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global in-vitro fertilization microscopes market is expected to garner $250.4 million in...
PharmAla Biotech to supply Clinical Psychedelic Lab at Monash University Clinical Trial with LaNeo MDMA
April 20, 2023 08:00 ET
|
PharmAla Biotech
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech is proud to have been selected as the MDMA manufacturing partner for the Clinical Psychedelic Lab at Monash...
Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
April 19, 2023 08:30 ET
|
Compass Therapeutics
BOSTON, April 19, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics...